Organic reactions in strong alkalis. Part V. Alkali fusion of epoxides and ethers
作者:M. F. Ansell、I. S. Shepherd、B. C. L. Weedon
DOI:10.1039/j39710001840
日期:——
The results obtained from the alkalifusion of long-chain epoxy-acids indicate the occurrence of at least four different reaction pathways, one of which, a β-elimination reaction, appears to be novel for unactivated epoxides. This particular reaction is also shown to occur with simple acylic ethers, as exemplified by 11-alkoxyundecanoic acids.
[EN] SUBSTITUTED 2,3-BENZODIAZEPINES DERIVATIVES<br/>[FR] DÉRIVÉS DE 2,3-BENZODIAZÉPINES SUBSTITUÉS
申请人:BAYER AG
公开号:WO2021152113A1
公开(公告)日:2021-08-05
Derivatives of 2,3- benzodiazepines as inhibitors of Bromodomain and extra C-terminal domain (BET) proteins, in particular the BRD4 family member, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases for hyperproliferative disorders, in particular for tumor disorders. The 2,3- benzodiazepines derivatives according to the invention are active as inhibitors as well as degraders of BET proteins.
Novel oxy- and thio-substituted fatty acid analog substrates of myristoylating enzymes are provided which contain an oxygen or sulfur in place of a methylene group in a carbon position from 4 to 13 in the fatty acid chain of a C.sub.13 -C.sub.14 fatty acid or alkyl ester thereof.
Novel oxy- and thio-substituted fatty acid analog substrates of myristoylating enzymes are provided which contain an oxygen or sulfur in place of a methylene group in a carbon position from 4 to 13 in the fatty acid chain of a C₁₃-C₁₄ fatty acid or alkyl ester thereof.
A method of inhibiting parasitic activity is disclosed in which the biosynthesis of the glycosyl phosphatidylinositol (GPI) anchor of said parasite is inhibited by incorporating into said GPI anchor an oxy-substituted fatty acid analog in place of myristate. The inhibitory compounds are C₁₃ and C₁₄ fatty acids or alkyl esters thereof in which a methylene group normally in carbon position 4 to 13 of said fatty acid is replaced with oxygen.